Once released, soluble NLGN3 (sNLGN3) diffuses to glioma cells and binds surface receptors, inducing the FAK-PI3K-mTOR signaling pathway that results in glioma cell proliferation [32,84,85,86]. This evidence concerns the gene NLGN3 and central nervous system cancer.